Every year, members of the Association of the British Pharmaceutical Industry are required to disclose money that has been paid to healthcare organizations.
Disclosures reveal that pharmaceutical companies have paid UK healthcare organizations £404 million over the three years 2020-2022 - £150 million, or 37%, was made by five pharmaceutical companies: GlaxoSmithKline, Sanofi Aventis, Novartis, Pfizer and AstraZeneca.
Using the same basis as we used in our previous article for healthcare professionals, we have aggregated the data in the Disclosure UK database for the years 2020 to 2023 for the Transfer of Values from pharmaceutical companies to healthcare organisations.
In total, pharmaceutical companies have paid £403.7 million to healthcare organizations over the three years 2020 to 2023, with nearly £338.5 million coming from just 20 pharmaceutical companies.
Topping the list for HCOs is GSK. Of the $12.5 million GSK paid to HCOs in 2022, £9.6 million went to 20 institutions with King's College London being by far the largest beneficiary.
GSK Payments to King's College London If a search is conducted for "King's College London" on the Disclosure UK website, there are several healthcare organizations or "Institution names" that are returned.
In 2022, under the "Aggregate" category, GSK paid unnamed HCPs, HCOs and other relevant decision-makers £29.5 million for research and development activities, which is significantly higher than the previous two years, suggesting the GSK/King's partnership expenses are being disclosed under the "Aggregate" category.
https://expose-news.com/2024/05/12/big-pharma-have-paid-uk-hocs-404-million/
No comments:
Post a Comment